Clinical Trial Update: High Clopidogrel Dose Versus Prasugrel and Ticagrelor in High Reactive Stable Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing high-dose clopidogrel with prasugrel and ticagrelor in patients with high platelet reactivity and stable coronary artery disease has c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)
• PRASUGREL (prasugrel)
• TICAGRELOR (ticagrelor)

Snippet

Sponsor: University of Roma La Sapienza | Conditions: Coronary Artery Disease | Phase 3 | Status: COMPLETED